Literature DB >> 27560641

Micro RNAs: an arguable appraisal in medicine.

K Voglova, J Bezakova, Iveta Herichova.   

Abstract

Micro RNAs (miRNAs) represent a newly discovered class of regulatory molecules in the human body. miRNA is a short double stranded RNA sequence interfering with mRNA, causing in most cases, inhibition of translation. Synthesis of miRNAs shows an increasing developmental pattern and postnatally miRNAs are synthesized in all cells possessing transcriptional machinery. miRNAs usually target several mRNAs and therefore conclusive evidences proving their functions are not always ease to be acquired. In spite of this difficulty, functions of miRNAs were firmly established in the development, the cardiovascular and neural diseases, and cancer. Many miRNAs have been reported to be associated with physiological state of cells and/or tissues. This finding becomes fundamental, especially when consider that these miRNAs can be released from cell into intracellular space or circulation. Correlation between miRNA production in tissues and its contribution to multisource miRNA pool in the circulation is in a focus of biomarker-oriented researchers. Recently, circulating miRNAs have been suggested to be applicable as biomarkers in several types of cancer, cardiovascular injury, and diabetes. Role of miRNAs in the organism intercellular signaling is still under the broad investigation. Several miRNA mimics, intended for treatment of disease, are being currently tested in the clinical trials.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27560641     DOI: 10.1515/enr-2016-0013

Source DB:  PubMed          Journal:  Endocr Regul        ISSN: 1210-0668


  5 in total

1.  Effects of the antagomiRs 15b and 200b on the altered healing pattern of diabetic mice.

Authors:  Gabriele Pizzino; Natasha Irrera; Federica Galfo; Giovanni Pallio; Federica Mannino; Angelica D'amore; Enrica Pellegrino; Antonio Ieni; Giuseppina T Russo; Marco Calapai; Domenica Altavilla; Francesco Squadrito; Alessandra Bitto
Journal:  Br J Pharmacol       Date:  2018-01-18       Impact factor: 8.739

2.  Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells.

Authors:  Wenying Huo; Guannan Zhao; Jinggang Yin; Xuan Ouyang; Yinan Wang; Chuanhe Yang; Baojing Wang; Peixin Dong; Zhixiang Wang; Hidemichi Watari; Edward Chaum; Lawrence M Pfeffer; Junming Yue
Journal:  J Cancer       Date:  2017-01-01       Impact factor: 4.207

3.  The Effect of Composol Medium on miR-16 Expression during Platelet Storage up to Day 7 at Room Temperature.

Authors:  Ali Rajabi; Zohreh Sharifi; Fatemeh Yari; Mohammad Reza Deyhim; Mohammad Ali Jalili
Journal:  Cell J       Date:  2020-04-22       Impact factor: 2.479

4.  MicroRNAs in porcine uterus and serum are affected by zearalenone and represent a new target for mycotoxin biomarker discovery.

Authors:  Bertrand Grenier; Matthias Hackl; Susanna Skalicky; Michaela Thamhesl; Wulf-Dieter Moll; Roger Berrios; Gerd Schatzmayr; Veronika Nagl
Journal:  Sci Rep       Date:  2019-06-28       Impact factor: 4.379

Review 5.  Therapeutic Targeting of Intestinal Fibrosis in Crohn's Disease.

Authors:  Giovanni Santacroce; Marco Vincenzo Lenti; Antonio Di Sabatino
Journal:  Cells       Date:  2022-01-26       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.